108425000: Granisetron hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\5-HT3 receptor antagonist\Granisetron hydrochloride

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\5-HT3 receptor antagonist\Granisetron hydrochloride

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Granisetron hydrochloride

\Organic compound\Organic cyclic compound\Heterocyclic compound\Indazole (substance)\Granisetron hydrochloride
\Organic compound\Aza compound (substance)\Azabicyclo compound (substance)\Granisetron hydrochloride
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Granisetron hydrochloride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

172959012 Granisetron hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

600607013 Granisetron hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3191461000005113 granisetronhydrochlorid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Granisetron hydrochloride	Is a	Product containing granisetron (medicinal product)	false	Inferred relationship	Some
Granisetron hydrochloride	Is a	Granisetron (substance)	false	Inferred relationship	Some
Granisetron hydrochloride	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	5-HT3 receptor antagonist	true	Inferred relationship	Some
Granisetron hydrochloride	Is a	Azabicyclo compound (substance)	true	Inferred relationship	Some
Granisetron hydrochloride	Is a	5-HT3 receptor antagonist	true	Inferred relationship	Some
Granisetron hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Granisetron (substance)	true	Inferred relationship	Some
Granisetron hydrochloride	Is a	Drug allergen	false	Inferred relationship	Some
Granisetron hydrochloride	Is a	Indazole (substance)	true	Inferred relationship	Some
Granisetron hydrochloride	Is a	Amide	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Granisetron hydrochloride 1.12mg/4 mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some
Granisetron (as granisetron hydrochloride) 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some
granisetron 1 mg/ml infusionsvæske, koncentrat, ampul a 3 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some
granisetron 1 mg/1 ml intravenøs opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some
granisetron 200 µg/ml væske til pædiatrisk anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some
granisetronhydrochlorid 1 mg/1 m l injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some
granisetron 0,1 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some
granisetronhydrochlorid 1 mg/1 ml injektionsvæske, opløsning, hætteglas a 4 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some	1
Granisetron (as granisetron hydrochloride) 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Granisetron hydrochloride	Inferred relationship	Some	1
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Granisetron hydrochloride	Inferred relationship	Some	1
Granisetron (as granisetron hydrochloride) 2 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Granisetron hydrochloride	Inferred relationship	Some	1
Product containing precisely granisetron (as granisetron hydrochloride) 200 microgram/1 milliliter conventional release oral solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Granisetron hydrochloride	Inferred relationship	Some	1
Product containing precisely granisetron (as granisetron hydrochloride) 3 milligram/3 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Granisetron hydrochloride	Inferred relationship	Some	1
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Granisetron hydrochloride	Inferred relationship	Some	1
Granisetron (as granisetron hydrochloride) 1 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Granisetron hydrochloride	Inferred relationship	Some	1

This concept is not in any reference sets